Contents

Reviews on Recent Clinical Trials, Volume 2 - Number 3

Radiation Therapy Plus Angiogenesis Inhibition with Bevacizumab: Rationale and Initial Experience

, 2(3): 163 - 168

Carsten Nieder, Nicole Wiedenmann, Nicolaus H. Andratschke, Sabrina T. Astner and Michael Molls


DOI: 10.2174/157488707781662733




Intraperitoneal Chemotherapy as Primary Treatment of Advanced Ovarian Cancer:Efficacy, Toxicity, and Future Directions

, 2(3): 169 - 173

Maurie Markman


DOI: 10.2174/157488707781662698




Update on Medical and Surgical Management of Intracerebral Hemorrhage

, 2(3): 174 - 181

Raymond Tak Fai Cheung


DOI: 10.2174/157488707781662751




Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen

, 2(3): 182 - 190

William C. Olson, Warren D.W. Heston and Ayyappan K. Rajasekaran


DOI: 10.2174/157488707781662724




Systemic Therapeutic Options in Thymic Malignancies: A Glimmer of Hope

, 2(3): 191 - 205

Lisa A. Hammond-Thelin, Charles R. Thomas and Jr.


DOI: 10.2174/157488707781662689




Standards and Novel Therapeutic Options in the Treatment of Patients with Soft Tissue Sarcoma

, 2(3): 206 - 211

Bernd Kasper


DOI: 10.2174/157488707781662706




Selective Internal Radiation Therapy with Yttrium-90 for Unresectable Liver Tumours

, 2(3): 212 - 216

Malika Khodjibekova, Teresa Szyszko, Sameer Khan, Kuldip Nijran, Paul Tait and Adil AL-Nahhas


DOI: 10.2174/157488707781662742




Dissection of Signal Transduction Pathways as a Tool for the Development of Targeted Therapies of Hepatocellular Carcinoma

, 2(3): 217 - 236

Diego F. Calvisi, Rosa M. Pascale and Francesco Feo


DOI: 10.2174/157488707781662715




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science